In addition, analysis of the CLL cells for phosphatidylcholine (PtC)-specificity of the BCR, indicative for a B-1 cell origin (37), showed that MyD88-deficiency had no major effect on the usage of the PtC-specific stereotypic BCR (Figure S3B). Here, MYD88 is linked to B-cell chronic lymphocytic leukemia.